{
  "timestamp": "20250103_205718",
  "model": "gpt-4o",
  "interaction_type": "direct_answer",
  "question_id": "d88f90a2",
  "question_text": "Drug of choice for relapsing remitting multiple sclerosis is:",
  "messages": [
    {
      "role": "system",
      "content": "You are a medical expert making decisions based on medical knowledge."
    },
    {
      "role": "user",
      "content": "You are a medical expert specializing in the field of Pharmacology.Please help answer this multiple choice question:\n\nQuestion: Drug of choice for relapsing remitting multiple sclerosis is:\n\nOptions:\nopa. Alpha IEN\nopb. Beta IFN\nopc. Gamma IFN\nopd. Natalizumab\n\n        ### Output Format\n        Provide your response in valid JSON format:\n        {   \n            \"final_analysis\": \"Your concise analysis following the above structure\",\n            \"answer\": \"Option key from the available options (only key,like opa)\",\n            \"confidence\": Score between 0-100 based on alignment with established medical facts\n        }\n        "
    }
  ],
  "response": "```json\n{\n    \"final_analysis\": \"The drug of choice for relapsing-remitting multiple sclerosis (RRMS) is typically a disease-modifying therapy. Beta interferons (Beta IFN) are among the first-line treatments for RRMS. They help reduce the frequency and severity of relapses. Natalizumab is also used for RRMS, especially in cases where patients have not responded adequately to other treatments or have more aggressive disease. However, Beta IFN is more commonly considered the initial drug of choice.\",\n    \"answer\": \"opb\",\n    \"confidence\": 90\n}\n```",
  "metadata": {
    "topic": "Pharmacology",
    "is_multi_choice": true,
    "has_reasoning_chain": false,
    "has_enhanced_info": false,
    "model_config": "gpt-4o",
    "temperature": 0.0
  }
}